Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease
Authors:
- 1 September 2014
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy Clinical Development
- Vol. 25 (3) , 134-163
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.Keywords
This publication has 124 references indexed in Scilit:
- Inspiratory muscle training in a child with nemaline myopathy and organ transplantationPediatric Critical Care Medicine, 2011
- Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational studyCritical Care, 2010
- Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established DiseaseMolecular Therapy, 2010
- Prolonged mechanical ventilation alters diaphragmatic structure and functionCritical Care Medicine, 2009
- Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapyProceedings of the National Academy of Sciences, 2009
- Neural deficits contribute to respiratory insufficiency in Pompe diseaseProceedings of the National Academy of Sciences, 2009
- Temporal Neuropathologic and Behavioral Phenotype of 6neo/6neoPompe Disease MiceJournal of Neuropathology & Experimental Neurology, 2008
- Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary diseaseThe Journal of Physiology, 2008
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Abnormalities of diaphragmatic muscle in neonates with ventilated lungsThe Journal of Pediatrics, 1988